DACT3-AS1, functioning as a tumor suppressor and exhibiting low expression in CAFs, fosters ferroptosis and enhances tumor cell sensitivity to oxaliplatin via the DACT3-AS1/miR-181a-5p/SIRT1 pathway (76). The gene discussed is DACT3; the disease is neoplasm.